Editorial
Pancreaticoduodenectomy for pancreatic cancer: perspective from the United States
Chinese Clinical Oncology
2017;
6
(1)
:1
.
(23 February 2017)
Improving clinical outcomes with pembrolizumab in patients with advanced melanoma
Chinese Clinical Oncology
2017;
6
(1)
:2
.
(23 February 2017)
PARP inhibitor and platinum agent in triple negative breast cancer: utilizing innovative trial design to bring together something “new” and something “old”
Chinese Clinical Oncology
2017;
6
(1)
:3
.
(23 February 2017)
An ICGC major achievement in breast cancer: a comprehensive catalog of mutations and mutational signatures
Chinese Clinical Oncology
2017;
6
(1)
:4
.
(23 February 2017)
Beginnings of a “gene cloud” definition in hepatocellular carcinoma
Chinese Clinical Oncology
2017;
6
(1)
:5
.
(23 February 2017)
Original Article
Comparison of short-term outcomes between laparoscopic-assisted and open complete mesocolic excision (CME) for the treatment of transverse colon cancer
Chinese Clinical Oncology
2017;
6
(1)
:6
.
(23 February 2017)
Review Article
Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)
Chinese Clinical Oncology
2017;
6
(1)
:7
.
(23 February 2017)
The prospective of laparoscopic pancreaticoduodenectomy for cancer management
Chinese Clinical Oncology
2017;
6
(1)
:8
.
(23 February 2017)
Commentary
The promise of using histone deacetylase inhibitors in combination treatment against breast cancer and other solid tumors
Chinese Clinical Oncology
2017;
6
(1)
:9
.
(23 February 2017)
Commentary on “LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress”
Chinese Clinical Oncology
2017;
6
(1)
:10
.
(23 February 2017)
Your View
Future prospect of gallbladder therapy using Hedgehog signaling inhibitor
Chinese Clinical Oncology
2017;
6
(1)
:11
.
(23 February 2017)
Chromodomain-helicase-DNA-binding protein 4: a novel therapeutic target in liver cancer stem cells
Chinese Clinical Oncology
2017;
6
(1)
:12
.
(23 February 2017)
Meet the Professor1
Professor Norman Wolmark: perseverance sometimes pays off
Chinese Clinical Oncology
2017;
6
(1)
:13
.
(23 February 2017)
Disclosure:
1. The series “Meet the Professor” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding.
